Appraisal of anti-gout potential of colchicine-loaded chitosan nanoparticle gel in uric acid-induced gout animal model

References

• Abd, E., et al., 2018. Minoxidil skin delivery from nanoemulsion formulations containing eucalyptol or oleic acid: enhanced diffusivity and follicular targeting. Pharmaceutics, 10 (1), 19.
   PubMed Web of Science ®Google Scholar
• Agnihotri, S.A., and Aminabhavi, T.M., 2004. Controlled release of clozapine through chitosan microparticles prepared by a novel method. Journal of controlled release, 96 (2), 245–259.
   PubMed Web of Science ®Google Scholar
• Agrawal, P., et al., 2017. TPGS-chitosan cross-linked targeted nanoparticles for effective brain cancer therapy. Materials science and engineering: C, 74, 167–176.
   PubMed Web of Science ®Google Scholar
• Aksu, N.B., et al., 2019. Preparation and evaluation of QbD based fusidic acid loaded in situ gel formulations for burn wound treatment. Journal of drug delivery science and technology, 52, 110–121.
   Web of Science ®Google Scholar
• Banerjee, T., et al., 2002. Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles. International journal of pharmaceutics, 243 (1-2), 93–105.
   PubMed Web of Science ®Google Scholar
• Bonnel, R.A., et al., 2002. Deaths associated with inappropriate intravenous colchicine administration1. The journal of emergency medicine, 22 (4), 385–387.
   PubMed Web of Science ®Google Scholar
• Chilappa, C.S., et al., 2010. Gout and hyperuricemia. Comprehensive therapy, 36, 3–13.
   PubMedGoogle Scholar
• Dalbeth, N., 2007. Gout—hit the target. Best practice journal, 8, 9–18.
   Google Scholar
• Dalbeth, N., Lauterio, T.J., and Wolfe, H.R., 2014. Mechanism of action of colchicine in the treatment of gout. Clinical therapeutics, 36 (10), 1465–1479.
   PubMed Web of Science ®Google Scholar
• Das, G.S., et al., 2000. Colchicine encapsulation within poly(ethylene glycol)-coated poly(lactic acid)/poly(epsilon-caprolactone) microspheres-controlled release studies. Drug delivery, 7 (3), 129–138.
   PubMed Web of Science ®Google Scholar
• Fernandes, R.S., et al., 2018. Nanostructured lipid carrier co-loaded with doxorubicin and docosahexaenoic acid as a theranostic agent: evaluation of biodistribution and antitumor activity in experimental model. Molecular imaging and biology, 20 (3), 437–447.
   PubMed Web of Science ®Google Scholar
• Khalil, R., et al., 2014. Polymeric nanoparticles as potential carriers for topical delivery of colchicine: development and in vitro characterization. International journal of pharmaceutical sciences and research, 5 (5), 1746.
   Google Scholar
• Kou, Y.-Y., et al., 2015. Effects of RuPeng15 Powder (RPP15) on monosodium urate crystal-induced gouty arthritis in rats. Evidence-based complementary and alternative medicine, 2015, 1.
   Web of Science ®Google Scholar
• Kumar, M.N.V., 2000. A review of chitin and chitosan applications. Reactive and functional polymers, 46 (1), 1–27.
   Web of Science ®Google Scholar
• Lin, M., et al., 2016. Curcumin-guided nanotherapy: a lipid-based nanomedicine for targeted drug delivery in breast cancer therapy. Drug delivery, 23 (4), 1420–1425.
   PubMed Web of Science ®Google Scholar
• Martinon, F., 2010. Mechanisms of uric acid crystal‐mediated autoinflammation. Immunological reviews, 233 (1), 218–232.
   PubMedGoogle Scholar
• Mohamed, D.A., and Al-Okbi, S.Y., 2008. Evaluation of anti-gout activity of some plant food extracts. Polish journal of food and nutrition sciences, 58 (3), 389–395.
   Google Scholar
• Nascimento, E. G. D., et al., 2009. Evaluation of chitosan gel with 1% silver sulfadiazine as an alternative for burn wound treatment in rats. Acta cirurgica brasileira, 24 (6), 460–465.
   PubMed Web of Science ®Google Scholar
• Negi, L.M., et al., 2019. Hyaluronated imatinib liposomes with hybrid approach to target CD44 and P-gp overexpressing MDR cancer: an in-vitro, in-vivo and mechanistic investigation. Journal of drug targeting, 27 (2), 183–192.
   PubMed Web of Science ®Google Scholar
• Neogi, T., 2011. Gout. New England journal of medicine, 364 (5), 443–452.
   PubMed Web of Science ®Google Scholar
• Okur, N.Ü., et al., 2019. Improving therapeutic efficacy of voriconazole against fungal keratitis: thermo-sensitive in situ gels as ophthalmic drug carriers. Journal of drug delivery science and technology, 49, 323–333.
   Web of Science ®Google Scholar
• Parashar, P., et al., 2018. Hyaluronic acid decorated naringenin nanoparticles: appraisal of chemopreventive and curative potential for lung cancer. Pharmaceutics, 10 (1), 33.
   PubMed Web of Science ®Google Scholar
• Parashar, P., et al., 2019a. A synergistic Approach for management of lung carcinoma through Folic acid functionalized co-therapy of capsaicin and gefitinib nanoparticles: enhanced apoptosis and metalloproteinase-9 down-regulation. Phytomedicine, 53, 107–123.
   PubMed Web of Science ®Google Scholar
• Parashar, P., et al., 2019b. A facile approach for fabricating CD44-targeted delivery of hyaluronic acid-functionalized PCL nanoparticles in urethane-induced lung cancer: Bcl-2, MMP-9, caspase-9, and BAX as potential markers. Drug delivery and translational research, 9 (1), 37–52.
   PubMed Web of Science ®Google Scholar
• Patel, K.K., et al., 2019. Alginate lyase immobilized chitosan nanoparticles of ciprofloxacin for the improved antimicrobial activity against the biofilm associated mucoid P. aeruginosa infection in cystic fibrosis. International journal of pharmaceutics, 563, 30–42.
   PubMed Web of Science ®Google Scholar
• Peng, C., Zhao, Q., and Gao, C., 2010. Sustained delivery of doxorubicin by porous CaCO3 and chitosan/alginate multilayers-coated CaCO3 microparticles. Colloids and surfaces A: physicochemical and engineering aspects, 353 (2–3), 132–139.
   Web of Science ®Google Scholar
• Qu, X., Wirsén, A., and Albertsson, A.-C., 1999. Structural change and swelling mechanism of pH‐sensitive hydrogels based on chitosan and D, L‐lactic acid. Journal of applied polymer science, 74 (13), 3186–3192.
   Web of Science ®Google Scholar
• Rawat, D., et al., 2015. Development and characterization of nanostructured lipid carriers of Vetiveria zizanoides oil for therapeutic potential in prickly heat treatment. Journal of pharmaceutical sciences and pharmacology, 2 (2), 162–171.
   Google Scholar
• Robinson, P.C., Taylor, W.J., and Dalbeth, N., 2015. An observational study of gout prevalence and quality of care in a national Australian general practice population. The journal of rheumatology, 42 (9), 1702–1707.
   PubMed Web of Science ®Google Scholar
• Sallam, M.A., and Boscá, M.T.M., 2015. Optimization, ex vivo permeation, and stability study of lipid nanocarrier loaded gelatin capsules for treatment of intermittent claudication. International journal of nanomedicine, 10, 4459.
   PubMed Web of Science ®Google Scholar
• Shen, Q., Wang, Y., and Zhang, Y., 2011. Improvement of colchicine oral bioavailability by incorporating eugenol in the nanoemulsion as an oil excipient and enhancer. International journal of nanomedicine, 6, 1237.
   PubMed Web of Science ®Google Scholar
• Siafaka, P.I., et al., 2015. Chitosan derivatives as effective nanocarriers for ocular release of timolol drug. International journal of pharmaceutics, 495 (1), 249–264.
   PubMed Web of Science ®Google Scholar
• Siafaka, P.I., et al., 2016. Surface modified multifunctional and stimuli responsive nanoparticles for drug targeting: current status and uses. International journal of molecular sciences, 17 (9), 1440.
   PubMed Web of Science ®Google Scholar
• Singh, H.P., Tiwary, A.K., and Jain, S., 2010. Preparation and in vitro, in vivo characterization of elastic liposomes encapsulating cyclodextrin-colchicine complexes for topical delivery of colchicine. Yakugaku zasshi, 130 (3), 397–407.
   PubMed Web of Science ®Google Scholar
• Singh, M., et al., 2016. Topical delivery of fluconazole via microemulsion incorporated hydrogel for the management of fungal dermatophytosis. Current drug therapy, 11 (2), 129–141.
   Web of Science ®Google Scholar
• Singh, M., et al., 2018. Assessment of improved buccal permeation and bioavailability of felodipine microemulsion-based cross-linked polycarbophil gel. Drug delivery and translational research, 8 (3), 591–601.
   PubMed Web of Science ®Google Scholar
• Singh, N., et al., 2017. Oral delivery of allopurinol niosomes in treatment of gout in animal model. Journal of liposome research, 27 (2), 130–138.
   PubMed Web of Science ®Google Scholar
• Singh, S., et al., 2017. Transdermal potential and anti-gout efficacy of febuxostat from niosomal gel. Journal of drug delivery science and technology, 39, 348–361.
   Web of Science ®Google Scholar
• Tan, Q., et al., 2011. Preparation and evaluation of quercetin-loaded lecithin-chitosan nanoparticles for topical delivery. International journal of nanomedicine, 6, 1621–1630.
   PubMed Web of Science ®Google Scholar
• Tiwari, S., et al., 2015. Urate crystal degradation for treatment of gout: a nanoparticulate combination therapy approach. Drug delivery and translational research, 5 (3), 219–230.
   PubMed Web of Science ®Google Scholar
• Tripathi, C.B., et al., 2018. ω-3 Fatty acid synergized novel nanoemulsifying system for rosuvastatin delivery: in vitro and in vivo evaluation. AAPS pharmscitech, 19 (3), 1205–1218.
   PubMed Web of Science ®Google Scholar
• Verma, J., et al., 2017. Wound healing applications of sericin/chitosan-capped silver nanoparticles incorporated hydrogel. Drug delivery and translational research, 7 (1), 77–88.
   PubMed Web of Science ®Google Scholar
• Wilson, B., et al., 2010. Chitosan nanoparticles as a new delivery system for the anti-Alzheimer drug tacrine. Nanomedicine, 6 (1), 144–152.
   PubMed Web of Science ®Google Scholar
• Wortmann, R.L., 2002. Gout and hyperuricemia. Current opinion in rheumatology, 14 (3), 281–286.
   PubMed Web of Science ®Google Scholar
• Zakir, F., et al., 2010. Development and characterization of oleic acid vesicles for the topical delivery of fluconazole. Drug delivery, 17 (4), 238–248.
   PubMed Web of Science ®Google Scholar